These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 29284061)
1. Correction: Gene Expression Differences in Peripheral Blood of Parkinson's Disease Patients with Distinct Progression Profiles. Pinho R; Guedes LC; Soreq L; Lobo PP; Mestre T; Coelho M; Rosa MM; Gonçalves N; Wales P; Mendes T; Gerhardt E; Fahlbusch C; Bonifati V; Bonin M; Miltenberger-Miltényi G; Borovecki F; Soreq H; Ferreira JJ; Outeiro TF PLoS One; 2017; 12(12):e0190552. PubMed ID: 29284061 [TBL] [Abstract][Full Text] [Related]
2. Correction: Voluntary and spontaneous facial mimicry toward other's emotional expression in patients with Parkinson's disease. Kang J; Derva D; Kwon DY; Wallraven C PLoS One; 2019; 14(5):e0217715. PubMed ID: 31136633 [TBL] [Abstract][Full Text] [Related]
3. Correction: Parkinson's disease-associated genetic variation is linked to quantitative expression of inflammatory genes. PLOS ONE Staff PLoS One; 2019; 14(1):e0210931. PubMed ID: 30640951 [TBL] [Abstract][Full Text] [Related]
4. Correction: Long-Latency Somatosensory Evoked Potentials of the Subthalamic Nucleus in Patients with Parkinson's Disease. Trenado C; Elben S; Friggemann L; Gruhn S; Groiss SJ; Vesper J; Schnitzler A; Wojtecki L PLoS One; 2017; 12(4):e0175602. PubMed ID: 28384357 [TBL] [Abstract][Full Text] [Related]
5. Correction: Motor planning error in Parkinson's disease and its clinical correlates. Kawasaki T; Mikami K; Kamo T; Aoki R; Ishiguro R; Nakamura H; Tozawa R; Asada N; Hiiragi Y; Yamada Y; Hirano M; Katsuki K PLoS One; 2020; 15(1):e0228698. PubMed ID: 31999803 [TBL] [Abstract][Full Text] [Related]
6. Correction: Exploring the reproducibility of functional connectivity alterations in Parkinson's disease. Badea L; Onu M; Wu T; Roceanu A; Bajenaru O PLoS One; 2018; 13(5):e0197121. PubMed ID: 29723284 [TBL] [Abstract][Full Text] [Related]
7. Correction: Impact of disease stage and age at Parkinson's onset on patients' primary concerns: Insights for targeted management. Bhidayasiri R; Boonmongkol T; Thongchuam Y; Phumphid S; Kantachadvanich N; Panyakaew P; Jagota P; Plengsri R; Chokpatcharavate M; Phokaewvarangkul O PLoS One; 2021; 16(6):e0252988. PubMed ID: 34086812 [TBL] [Abstract][Full Text] [Related]
8. Correction: A genetic analysis of a Spanish population with early onset Parkinson's disease. PLOS ONE Staff PLoS One; 2021; 16(4):e0249805. PubMed ID: 33819307 [TBL] [Abstract][Full Text] [Related]
9. Correction: The related factors of sleep benefit in Parkinson's disease: A systematic review and meta-analysis. Zhong R; Chen Q; Zhang X; Zhang X; Lin W PLoS One; 2019; 14(5):e0216524. PubMed ID: 31042758 [TBL] [Abstract][Full Text] [Related]
10. Correction: Lower levels of uric acid and striatal dopamine in non-tremor dominant Parkinson's disease subtype. PLOS ONE Staff PLoS One; 2017; 12(4):e0176628. PubMed ID: 28445525 [TBL] [Abstract][Full Text] [Related]
11. Correction: A compound downregulation of SRRM2 and miR-27a-3p with upregulation of miR-27b-3p in PBMCs of Parkinson's patients is associated with the early stage onset of disease. Fazeli S; Motovali-Bashi M; Peymani M; Hashemi MS; Etemadifar M; Hossein Nasr-Esfahani M; Ghaedi K PLoS One; 2020; 15(12):e0244776. PubMed ID: 33378389 [TBL] [Abstract][Full Text] [Related]
12. Correction: Reduced Topological Efficiency in Cortical-Basal Ganglia Motor Network of Parkinson's Disease: A Resting State fMRI Study. Wei L; Zhang J; Long Z; Wu GR; Hu X; Zhang Y; Wang J PLoS One; 2018; 13(7):e0200623. PubMed ID: 29990373 [TBL] [Abstract][Full Text] [Related]
13. Correction: An Anti-Parkinson's Disease Drug via Targeting Adenosine A2A Receptor Enhances Amyloid-β Generation and γ-Secretase Activity. PLOS ONE Staff PLoS One; 2017; 12(2):e0172775. PubMed ID: 28207857 [TBL] [Abstract][Full Text] [Related]
14. Correction: The Screening Visual Complaints questionnaire (SVCq) in people with Parkinson's disease-Confirmatory factor analysis and advice for its use in clinical practice. PLOS ONE Editors PLoS One; 2022; 17(11):e0277781. PubMed ID: 36342949 [TBL] [Abstract][Full Text] [Related]
15. Correction: The Screening Visual Complaints questionnaire (SVCq) in people with Parkinson's disease-Confirmatory factor analysis and advice for its use in clinical practice. van der Lijn I; de Haan GA; van der Feen FE; Huizinga F; Fuermaier ABM; van Laar T; Heutink J PLoS One; 2022; 17(11):e0278279. PubMed ID: 36413555 [TBL] [Abstract][Full Text] [Related]
16. Correction: S-Nitrosylation of G protein-coupled receptor kinase 6 and Casein kinase 2 alpha modulates their kinase activity toward alpha-synuclein phosphorylation in an animal model of Parkinson's disease. Wu W; Sung CC; Yu P; Li J; Chung KKK PLoS One; 2020; 15(6):e0235296. PubMed ID: 32555609 [TBL] [Abstract][Full Text] [Related]
17. Correction: Statistical segmentation model for accurate electrode positioning in Parkinson's deep brain stimulation based on clinical low-resolution image data and electrophysiology. Varga I; Bakstein E; Gilmore G; May J; Novak D PLoS One; 2024; 19(4):e0302985. PubMed ID: 38683813 [TBL] [Abstract][Full Text] [Related]
18. Correction: Female and male mouse lung group 2 innate lymphoid cells differ in gene expression profiles and cytokine production. Mathä L; Shim H; Steer CA; Yin YH; Martinez-Gonzalez I; Takei F PLoS One; 2021; 16(5):e0252257. PubMed ID: 34015033 [TBL] [Abstract][Full Text] [Related]
19. Correction: Altered Blood Biomarker Profiles in Athletes with a History of Repetitive Head Impacts. Di Battista AP; Rhind SG; Richards D; Churchill N; Baker AJ; Hutchison MG PLoS One; 2016; 11(10):e0164912. PubMed ID: 27727300 [TBL] [Abstract][Full Text] [Related]
20. Correction: Utilization of urea and expression profiles of related genes in the dinoflagellate Prorocentrum donghaiense. Jing X; Lin S; Zhang H; Koerting C; Yu Z PLoS One; 2018; 13(1):e0191521. PubMed ID: 29338050 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]